ATE359778T1 - Mittel zur behandlung von myelopathie - Google Patents
Mittel zur behandlung von myelopathieInfo
- Publication number
- ATE359778T1 ATE359778T1 AT02728064T AT02728064T ATE359778T1 AT E359778 T1 ATE359778 T1 AT E359778T1 AT 02728064 T AT02728064 T AT 02728064T AT 02728064 T AT02728064 T AT 02728064T AT E359778 T1 ATE359778 T1 AT E359778T1
- Authority
- AT
- Austria
- Prior art keywords
- myelopathy
- compound
- hydrate
- alkyl
- general formula
- Prior art date
Links
- 206010028570 Myelopathy Diseases 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 2
- 230000003000 nontoxic effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000036982 Spinal cord ischaemia Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 208000020431 spinal cord injury Diseases 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Mushroom Cultivation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001147230 | 2001-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE359778T1 true ATE359778T1 (de) | 2007-05-15 |
Family
ID=18992747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02728064T ATE359778T1 (de) | 2001-05-17 | 2002-05-16 | Mittel zur behandlung von myelopathie |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050101633A1 (de) |
| EP (1) | EP1393727B1 (de) |
| JP (1) | JPWO2002092074A1 (de) |
| AT (1) | ATE359778T1 (de) |
| DE (1) | DE60219619T2 (de) |
| ES (1) | ES2284867T3 (de) |
| WO (1) | WO2002092074A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119638624A (zh) * | 2023-09-15 | 2025-03-18 | 上海壹迪生物技术有限公司 | 中性粒细胞弹性蛋白酶抑制剂及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0143565B1 (ko) * | 1988-06-13 | 1998-07-15 | 사노 가즈오 | 피발산의 p-치환된 페닐 에스테르 유도체, 그의 제조 방법 및 이를 포함하는 조성물. |
| EP0539223A1 (de) * | 1991-10-25 | 1993-04-28 | Ono Pharmaceutical Co., Ltd. | Tetrahydrat des Mononatriumsalzes eines Glycerinderivates, welches einen Elastase inhibierenden Effekt hat |
| US6552082B2 (en) * | 2000-06-29 | 2003-04-22 | Ono Pharmaceutical Co., Ltd. | Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof |
-
2002
- 2002-05-16 ES ES02728064T patent/ES2284867T3/es not_active Expired - Lifetime
- 2002-05-16 DE DE60219619T patent/DE60219619T2/de not_active Expired - Fee Related
- 2002-05-16 WO PCT/JP2002/004731 patent/WO2002092074A1/ja not_active Ceased
- 2002-05-16 US US10/477,716 patent/US20050101633A1/en not_active Abandoned
- 2002-05-16 AT AT02728064T patent/ATE359778T1/de not_active IP Right Cessation
- 2002-05-16 EP EP02728064A patent/EP1393727B1/de not_active Expired - Lifetime
- 2002-05-16 JP JP2002588991A patent/JPWO2002092074A1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20050101633A1 (en) | 2005-05-12 |
| EP1393727B1 (de) | 2007-04-18 |
| JPWO2002092074A1 (ja) | 2004-08-26 |
| ES2284867T3 (es) | 2007-11-16 |
| EP1393727A4 (de) | 2005-03-16 |
| EP1393727A1 (de) | 2004-03-03 |
| WO2002092074A1 (fr) | 2002-11-21 |
| DE60219619D1 (de) | 2007-05-31 |
| DE60219619T2 (de) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60119894D1 (de) | Piperidinverbindungen und diese enthaltenden medikamente | |
| NO20024424D0 (no) | Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater tilfremstilling av derivatene | |
| NO960380D0 (no) | Middel til behandling av neurosykdommer | |
| SE0104332D0 (sv) | Therapeutic agents | |
| ATE399782T1 (de) | Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| DE60102171D1 (de) | Ketolidantibiotika | |
| ATE325610T1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| AU9233101A (en) | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation | |
| DE69729213D1 (de) | Tricyclische aminderivate | |
| DE60002558D1 (de) | Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B | |
| ATE399550T1 (de) | Heilmittel und vorbeugende mittel für verdauungserkrankungen die diaminotrifluoromethylpyridinverbindungen enthalten | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| ATE332697T1 (de) | Cyanidinmischung zur behandlung von dickdarmkrebs | |
| ATE359778T1 (de) | Mittel zur behandlung von myelopathie | |
| ATE511395T1 (de) | Mittel zur behandlung von glomerulopathie | |
| ATE305783T1 (de) | Verwendung von diaminotrifluoromethylpyridinderivaten für die prevention und behandlung von lebererkrankungen | |
| DE60104589D1 (de) | Therapeutisches Mittel zur Behandlung von Dermatitis | |
| DE69911373D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| EP1693060A4 (de) | Mittel zur behandlung oder prävention von ischämischer neuropathie | |
| DE69902142D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| ATE423109T1 (de) | Diaminderivat, herstellungsverfahren und antioxidations-arzneimittel | |
| ATE175351T1 (de) | Therapeutisches mittel zur behandlung von ischämischen oder reperfusion schädigungen des myokards | |
| TH35765A (th) | อะริลซัลโฟนาไมด์และอะนาล๊อค |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |